TY  - GEN
AU  - Innominato,Pasquale F
AU  - Giacchetti,Sylvie
AU  - Moreau,Thierry
AU  - Smaaland,Rune
AU  - Focan,Christian
AU  - Bjarnason,Georg A
AU  - Garufi,Carlo
AU  - Iacobelli,Stefano
AU  - Tampellini,Marco
AU  - Tumolo,Salvatore
AU  - Carvalho,Carlos
AU  - Karaboué,Abdoulaye
AU  - Lévi,Francis
TI  - Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963)
SN  - 1525-6073
PY  - 2011///1206
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biological Clocks
KW  - physiology
KW  - Circadian Rhythm
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Fluorouracil
KW  - Humans
KW  - Leucovorin
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neutropenia
KW  - chemically induced
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Prognosis
KW  - Survival Analysis
KW  - Treatment Outcome
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3109/07420528.2011.597532
ER  -